» Articles » PMID: 20108782

[Pre-pregnancy and Early Clinical Analysis of TORCH Infections Detection]

Overview
Specialty Microbiology
Date 2010 Jan 30
PMID 20108782
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: For the birth, to improve the quality of the population, to explore the prevention and treatment of early pregnancy TORCH infection, and treatment of patients with positive eugenics and guidance.

Methods: Enzyme-linked immunosorbent assay (ELISA) testing of all the objects in the peripheral blood-money pathogen-specific antibodies LgM. Person in charge of testing. In strict accordance with the instructions. Reagents from Shanghai magnolia biotechnology institute.

Result: The total number of 319 cases of positive, with a total infection rate: 3.28%, TOX-IgM, RV-IgM, CMV-IgM, HSV (II)-IgM infection rate of 0.103 percent, 2.64 percent and 0.309 percent, 0.237 percent; 319 cases of TORCH infected persons are to receive treatment for the treatment of wrap, with a total negative rate of 97.49 percent.

Conclusion: Detection of TORCH infections to ensure early diagnosis, early treatment and early prevention is necessary.

Citing Articles

Effect of Gold Nanoparticles on Luminescence Enhancement in Antibodies for TORCH Detection.

Chen C, Ding P Molecules. 2024; 29(23).

PMID: 39683881 PMC: 11643928. DOI: 10.3390/molecules29235722.